Elżbieta Kozek

Suggest Changes
Learn More
INTRODUCTION AND OBJECTIVE Continuous subcutaneous insulin infusion (CSII) via personal insulin pump is a valuable therapeutic tool in T1DM patients. However, adherence to recommended CSII-related(More)